This video shows a step by step guide for women who have chosen to use subcutaneous DMPA-SC/Self Injection in the context of informed choice counseling. DMPA-SC/SI is a lower-dose, easy-to-use injectable contraceptive that is administered every three months. The product’s user-friendly design means that any trained person can administer it, including community health workers, pharmacists, and even women themselves.
Despite the novel COVID-19 pandemic that has disrupted health service delivery and caused backdrop for businesses in the past months, the RASuDiN Project continued to demonstrate the feasibility of expanding access to Family Planning (FP) method uptake, increasing self-care among women of reproductive age (WRA) and improving continuation rate of DMPA-SC/SI. ARFH RASuDiN project under […]
RASuDiN Policy Briefs: Empowering Women for a Healthier Future in Anambra, Enugu, Delta, Oyo, Lagos, Kwara, Niger, Plateau, Ogun and Rivers States
The Resilient & Accelerated Scale-up of DMPA-SC/Self-injection in Nigeria (RASuDiN) project aims to increase use, acceptance, availability, and accessibility of DMPA-SC, expanding the family planning method mix for women of reproductive age in Nigeria. The project is led by Association for Reproductive and Family Health (ARFH) in partnership with the Centre for Communication and Social […]
Investing in Family Planning has been identified as a “best buy” in accelerating the achievements of the Sustainable Development Goals (SDGs). The Government of Nigeria updated its commitment at the International Family Planning Summit in London, 2017, to achieve a modern contraceptive rate of 27% among all women of reproductive age by 2020 through working […]